AK
Ashawani Kumar Newatia
About Ashawani Kumar Newatia
Data last updated:
Ashawani Kumar Newatia is a Director at Panbross Pharmaceuticals Private Limited (since 2014) and Director at Anaar Pharmaceuticals Private Limited (since 1998). The companies operate in Pharma. The largest current company by reported revenue is Panbross Pharmaceuticals Private Limited at ₹1.8 Lakh (FY 2019).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 31 Oct 2014 | 1988 | ₹1.8 Lakh (FY 2019) | Active | |
| Director | 29 Jul 1998 | 1998 | Active |
Board colleagues of Ashawani Kumar Newatia
| Name | DIN | Company | Designation |
|---|---|---|---|
| Bimla Devi Newatia | 05133284 | Panbross Pharmaceuticals Private Limited | Director |
| Gopal Newatia | 00228121 | Panbross Pharmaceuticals Private Limited | Director |
| Niharika Newatia | 02167261 | Anaar Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Ashawani Kumar Newatia
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ashawani Kumar Newatia
Ashawani Kumar Newatia currently holds 2 directorships: Panbross Pharmaceuticals Private Limited (Director, since 31 Oct 2014, revenue ₹1.8 Lakh (FY 2019)); Anaar Pharmaceuticals Private Limited (Director, since 29 Jul 1998).
Ashawani Kumar Newatia was first appointed on 29 Jul 1998 as Director at Anaar Pharmaceuticals Private Limited. The most recent appointment on record is 31 Oct 2014 at Panbross Pharmaceuticals Private Limited.
The current boards of Ashawani Kumar Newatia's companies include Bimla Devi Newatia (Panbross Pharmaceuticals Private Limited), Gopal Newatia (Panbross Pharmaceuticals Private Limited), Niharika Newatia (Anaar Pharmaceuticals Private Limited).